92 results
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
7 Dec 23
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
8:41am
and funding shortages caused by the COVID-19 pandemic; uncertainties with respect to lengthy and expensive clinical trials, that results of earlier
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
protection and litigation; risks associated with delays, increased costs and funding shortages caused by the COVID-19 pandemic; uncertainties with respect
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
the COVID-19 pandemic) of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case
424B5
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Prospectus supplement for primary offering
4:52pm
pandemic. SARS-CoV-2 infection may, in some instances, be associated with acute lung injury and platelet-mediated thrombotic disorders. In experimental … by the COVID-19 pandemic;
Our ability to obtain regulatory approvals;
Our ability to maintain and protect intellectual property rights;
The inability
8-K
EX-99.1
8uzrcg 5se0
24 Jul 23
Regulation FD Disclosure
4:04pm
424B5
f0nl5hwq0ul l38
21 Jul 23
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.1
wchlm0s1 6m7i
22 May 23
Regulation FD Disclosure
1:05pm
8-K
EX-99.2
8pf 0kd304t0p5goy
22 May 23
Regulation FD Disclosure
1:05pm
8-K
EX-99.1
uldj792sxnqv
10 May 23
Hepion Pharmaceuticals, Inc. Announces Reverse Stock Split
5:17pm
8-K
EX-10.3
cf3lb zra0sy
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
8-K
EX-99.1
05hgzku
17 Oct 22
Regulation FD Disclosure
5:13pm
DEFA14A
9v5p2up1ylt4bnlmhyoi
22 Jul 22
Additional proxy soliciting materials
9:31pm
8-K
EX-99.1
u1ilt2h8x6h tjn7rb89
28 Jun 22
Departure of Directors or Certain Officers
9:46am
DEFA14A
mygtmuamh wnbipiyyg0
24 Jun 22
Additional proxy soliciting materials
4:24pm
DEFA14A
eh6wuj
31 May 22
Additional proxy soliciting materials
4:52pm
8-K
EX-99.2
8fvhi2yqrdf9lxwg1
27 May 22
Regulation FD Disclosure
8:44am